Early interim 2-(1)fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to peripheral blood lymphocyte/monocyte ratio at diagnosis in classical Hodgkin's lymphoma
- 1 June 2012
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 97 (6) , e21-e23
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphomaDiagnostic Pathology, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica, 2011
- Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphomaAnnals of Oncology, 2011
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaNew England Journal of Medicine, 2010
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 StudyJournal of Clinical Oncology, 2009
- The International Harmonization Project for Response Criteria in Lymphoma Clinical TrialsHematology/Oncology Clinics of North America, 2007
- Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish StudyJournal of Clinical Oncology, 2007
- The disappearance of prognostic factors in Hodgkin's diseaseAnnals of Oncology, 2002
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)Cancer Chemotherapy and Pharmacology, 1979